So far, 457 women in the U.S. have been diagnosed with anaplastic large cell lymphoma tied to breast implants. Nine of those patients have died from the rare cancer. Women with breast implants have an increased risk of developing it.
Since September, the FDA has received 660 medical device reports regarding cancer linked to breast implants.
“We hope that this information prompts providers and patients to have important, informed conversations about breast implants,” the FDA said.
More articles on clinical leadership & infection control:
Former Vanderbilt nurse indicted on reckless homicide charge after fatal medication error
Cedars-Sinai researchers test activity trackers to predict postoperative length of stay
Joint Commission launches new “Step Up” campaign to prevent infection
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
